Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sphere of biopharmaceuticals, presenting promising breakthroughs throughout a variety of health-related and industrial programs. With its structural similarity to Obviously derived human serum albumin, OsrHSA gives a safer, additional trustworthy alternative for thera